2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

François Mach; Colin Baigent; Alberico L. Catapano; Konstantinos C. Koskina; Manuela Casula; Lina Badimon; M. John Chapman; Guy G. De Backer; Victoria Delgado; Brian A. Ference; Ian M. Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R. Pedersen; Gabriele Riccardi; Dimitrios J. Richter; Marc S. Sabatine; Marja Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund; Stephan Windecker; Victor Aboyans; Jean Philippe Collet; Veronica Dean; Donna Fitzsimons; Chris P. Gale; Diederick Grobbee; Sigrun Halvorsen; Gerhard Hindricks; Bernard Iung; Peter Jüni; Hugo A. Katus; Christophe Leclercq; Maddalena Lettino; Basil S. Lewis; Bela Merkely; Christian Mueller; Steffen Petersen; Anna Sonia Petronio; Marco Roffi; Evgeny Shlyakhto; Iain A. Simpson; Miguel Sousa-Uva; Rhian M. Touyz; Djamaleddine Nibouche; Parounak H. Zelveian; Peter Siostrzonek; Ruslan Najafov; Philippe van de Borne; Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies

doi:10.1016/j.atherosclerosis.2019.08.014

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

François Mach^*, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskina, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja Riitta Taskinen, Lale TokgozogluOlov Wiklund, Stephan Windecker, Victor Aboyans, Jean Philippe Collet, Veronica Dean, Donna Fitzsimons, Chris P. Gale, Diederick Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Christophe Leclercq, Maddalena Lettino, Basil S. Lewis, Bela Merkely, Christian Mueller, Steffen Petersen, Anna Sonia Petronio, Marco Roffi, Evgeny Shlyakhto, Iain A. Simpson, Miguel Sousa-Uva, Rhian M. Touyz, Djamaleddine Nibouche, Parounak H. Zelveian, Peter Siostrzonek, Ruslan Najafov, Philippe van de Borne, Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies

^*Corresponding author for this work

School of Nursing and Midwifery

Research output: Contribution to journal › Article › peer-review

892 Citations (Scopus)

Original language	English
Pages (from-to)	140-205
Number of pages	66
Journal	Atherosclerosis
Volume	290
Early online date	31 Aug 2019
DOIs	https://doi.org/10.1016/j.atherosclerosis.2019.08.014
Publication status	Published - 01 Nov 2019

Keywords

Apolipoprotein B
Cholesterol;
Dyslipidaemias
Familial hypercholesterolaemia
Guidelines
High-density lipoproteins
Lipoprotein remnants
Lipoprotein(a)
Low-density lipoproteins
Total cardiovascular risk
Treatment (adherence)
Treatment (drugs)
Treatment (lifestyle)
Triglycerides
Very low-density lipoproteins

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.atherosclerosis.2019.08.014Licence: Unspecified

892 Citations
2 Comment/debate

Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]
Task Force Members, ESC National Cardiac Societies & ESC Committee for Practice Guidelines (CPG), Feb 2020, In: Atherosclerosis. 294, p. 80-82 3 p.
Research output: Contribution to journal › Comment/debate › peer-review

10 Citations (Scopus)
Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R. & Tokgozoglu, L. & 30 others, Wiklund, O., Nibouche, D., Zelveian, P. H., Siostrzonek, P., Najafov, R., van de Borne, P., Pojskic, B., Postadzhiyan, A., Kypris, L., Špinar, J., Larsen, M. L., Eldin, H. S., Viigimaa, M., Strandberg, T. E., Ferrieres, J., Agladze, R., Laufs, U., Rallidis, L., Bajnok, L., Gudjonsson, T., Maher, V., Henkin, Y., Gulizia, M. M., Mussagaliyeva, A., Bajraktari, G., Kerimkulova, A., Latkovskis, G., Hamoui, O., Slapikas, R. & Fitzsimons, D., 01 Jan 2020, In: Atherosclerosis. 292, p. 160-162 3 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
4 Citations (Scopus)

Cite this

Mach, F., Baigent, C., Catapano, A. L., Koskina, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., ... ESC National Cardiac Societies (2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, 140-205. https://doi.org/10.1016/j.atherosclerosis.2019.08.014

@article{c62a5722912c467ea3058a53cb8c5bf3,

title = "2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk",

keywords = "Apolipoprotein B, Cholesterol;, Dyslipidaemias, Familial hypercholesterolaemia, Guidelines, High-density lipoproteins, Lipoprotein remnants, Lipoprotein(a), Low-density lipoproteins, Total cardiovascular risk, Treatment (adherence), Treatment (drugs), Treatment (lifestyle), Triglycerides, Very low-density lipoproteins",

author = "Fran{\c c}ois Mach and Colin Baigent and Catapano, \{Alberico L.\} and Koskina, \{Konstantinos C.\} and Manuela Casula and Lina Badimon and Chapman, \{M. John\} and \{De Backer\}, \{Guy G.\} and Victoria Delgado and Ference, \{Brian A.\} and Graham, \{Ian M.\} and Alison Halliday and Ulf Landmesser and Borislava Mihaylova and Pedersen, \{Terje R.\} and Gabriele Riccardi and Richter, \{Dimitrios J.\} and Sabatine, \{Marc S.\} and Taskinen, \{Marja Riitta\} and Lale Tokgozoglu and Olov Wiklund and Stephan Windecker and Victor Aboyans and Collet, \{Jean Philippe\} and Veronica Dean and Donna Fitzsimons and Gale, \{Chris P.\} and Diederick Grobbee and Sigrun Halvorsen and Gerhard Hindricks and Bernard Iung and Peter J{\"u}ni and Katus, \{Hugo A.\} and Christophe Leclercq and Maddalena Lettino and Lewis, \{Basil S.\} and Bela Merkely and Christian Mueller and Steffen Petersen and Petronio, \{Anna Sonia\} and Marco Roffi and Evgeny Shlyakhto and Simpson, \{Iain A.\} and Miguel Sousa-Uva and Touyz, \{Rhian M.\} and Djamaleddine Nibouche and Zelveian, \{Parounak H.\} and Peter Siostrzonek and Ruslan Najafov and \{van de Borne\}, Philippe and \{Authors/Task Force Members\} and \{ESC Committee for Practice Guidelines (CPG)\} and \{ESC National Cardiac Societies\}",

year = "2019",

month = nov,

day = "1",

doi = "10.1016/j.atherosclerosis.2019.08.014",

language = "English",

volume = "290",

pages = "140--205",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

Mach, F, Baigent, C, Catapano, AL, Koskina, KC, Casula, M, Badimon, L, Chapman, MJ, De Backer, GG, Delgado, V, Ference, BA, Graham, IM, Halliday, A, Landmesser, U, Mihaylova, B, Pedersen, TR, Riccardi, G, Richter, DJ, Sabatine, MS, Taskinen, MR, Tokgozoglu, L, Wiklund, O, Windecker, S, Aboyans, V, Collet, JP, Dean, V, Fitzsimons, D, Gale, CP, Grobbee, D, Halvorsen, S, Hindricks, G, Iung, B, Jüni, P, Katus, HA, Leclercq, C, Lettino, M, Lewis, BS, Merkely, B, Mueller, C, Petersen, S, Petronio, AS, Roffi, M, Shlyakhto, E, Simpson, IA, Sousa-Uva, M, Touyz, RM, Nibouche, D, Zelveian, PH, Siostrzonek, P, Najafov, R, van de Borne, P, Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG) & ESC National Cardiac Societies 2019, '2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk', Atherosclerosis, vol. 290, pp. 140-205. https://doi.org/10.1016/j.atherosclerosis.2019.08.014

TY - JOUR

T1 - 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

AU - Mach, François

AU - Baigent, Colin

AU - Catapano, Alberico L.

AU - Koskina, Konstantinos C.

AU - Casula, Manuela

AU - Badimon, Lina

AU - Chapman, M. John

AU - De Backer, Guy G.

AU - Delgado, Victoria

AU - Ference, Brian A.

AU - Graham, Ian M.

AU - Halliday, Alison

AU - Landmesser, Ulf

AU - Mihaylova, Borislava

AU - Pedersen, Terje R.

AU - Riccardi, Gabriele

AU - Richter, Dimitrios J.

AU - Sabatine, Marc S.

AU - Taskinen, Marja Riitta

AU - Tokgozoglu, Lale

AU - Wiklund, Olov

AU - Windecker, Stephan

AU - Aboyans, Victor

AU - Collet, Jean Philippe

AU - Dean, Veronica

AU - Fitzsimons, Donna

AU - Gale, Chris P.

AU - Grobbee, Diederick

AU - Halvorsen, Sigrun

AU - Hindricks, Gerhard

AU - Iung, Bernard

AU - Jüni, Peter

AU - Katus, Hugo A.

AU - Leclercq, Christophe

AU - Lettino, Maddalena

AU - Lewis, Basil S.

AU - Merkely, Bela

AU - Mueller, Christian

AU - Petersen, Steffen

AU - Petronio, Anna Sonia

AU - Roffi, Marco

AU - Shlyakhto, Evgeny

AU - Simpson, Iain A.

AU - Sousa-Uva, Miguel

AU - Touyz, Rhian M.

AU - Nibouche, Djamaleddine

AU - Zelveian, Parounak H.

AU - Siostrzonek, Peter

AU - Najafov, Ruslan

AU - van de Borne, Philippe

AU - Authors/Task Force Members

AU - ESC Committee for Practice Guidelines (CPG)

AU - ESC National Cardiac Societies

PY - 2019/11/1

Y1 - 2019/11/1

KW - Apolipoprotein B

KW - Cholesterol;

KW - Dyslipidaemias

KW - Familial hypercholesterolaemia

KW - Guidelines

KW - High-density lipoproteins

KW - Lipoprotein remnants

KW - Lipoprotein(a)

KW - Low-density lipoproteins

KW - Total cardiovascular risk

KW - Treatment (adherence)

KW - Treatment (drugs)

KW - Treatment (lifestyle)

KW - Triglycerides

KW - Very low-density lipoproteins

U2 - 10.1016/j.atherosclerosis.2019.08.014

DO - 10.1016/j.atherosclerosis.2019.08.014

M3 - Article

AN - SCOPUS:85072794956

SN - 0021-9150

VL - 290

SP - 140

EP - 205

JO - Atherosclerosis

JF - Atherosclerosis

ER -

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Keywords

ASJC Scopus subject areas

Access to Document

Research output

Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

Cite this